Article
Integrating Genetic and Immune Profiles for Personalized Immunotherapy in Alzheimer’s Disease
2025-01-13
Abstract excerpt
Alzheimer's disease is the leading cause of dementia worldwide, with the number of patients expected to reach 131 million by 2050. Current treatments can only alleviate the symptoms of AD and are unable to halt the progression of the disease. Personalized immunotherapy shows great potential, as it can improve treatment efficacy and reduce side effects through precise targeting and early intervention. This pap...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5eda059e-5476-57de-abfd-138e24203672
- DOI
- 10.20944/preprints202501.0858.v1
